#United States #Phoenix #Regenerative Therapy #Matricelf Ltd #DSPN Summit

Matricelf to Attend the Digital Spine and Pain Neuroscience Summit 2026

Matricelf Ltd., a pioneering company in the field of regenerative medicine focused on personalized treatments for spinal cord injuries, has announced its participation in the Digital Spine & Pain Neuroscience Summit 2026. The event will take place in Phoenix, Arizona, from February 26 to March 1, 2026.

The Digital Spine & Pain Neuroscience Summit stands as a leading global platform for experts in the areas of spine care, neuroscience, and advanced therapeutic technologies. This year’s summit boasts a comprehensive lineup of scientific sessions, expert panels, and showcases of emerging technologies that aim to foster collaboration among professionals in the regenerative medicine community.

Matricelf's Objectives for the Summit

Matricelf’s senior leadership is set to engage with key opinion leaders, clinicians, and researchers specializing in spinal cord injuries. Significant objectives during the summit include:
1. Presenting Matricelf’s Neural Tissue Regeneration Platform: The company plans to showcase its innovative platform, which focuses on personalized solutions for neural tissue repair and regeneration.
2. Exploring Strategic Partnerships: By engaging with various stakeholders at the event, Matricelf aims to identify partners who can facilitate clinical translation, commercialization, and wider adoption of its therapies.
3. Highlights of Progress: The company will also discuss recent milestones, such as gaining ethical approvals and advancements toward commencing first-in-human clinical studies.

CEO of Matricelf, Gil Hakim, expressed enthusiasm about participating in the summit: “We are pleased to participate in the DSPN Spine Summit, where leading clinicians and innovators will convene. This Summit is an invaluable opportunity to share our vision and engage with the global community as we move toward human clinical studies in the U.S.”

About the DSPN Spine Summit

The Digital Spine & Pain Neuroscience Summit is a pivotal event dedicated to the integration of evidence-based science and innovative technologies for spine care and pain management. By bringing together multidisciplinary experts, the summit aims to create opportunities for collaboration and promote advancements that will shape the future direction of spine health.

About Matricelf Ltd.

Matricelf Ltd. (TASE: MTLF) is at the forefront of regenerative medicine, developing a unique personalized autologous neural tissue platform aimed at restoring function in patients suffering from spinal cord injuries. Through the utilization of patient-derived cells combined with proprietary tissue engineering, Matricelf is committed to advancing regenerative therapies from the laboratory into clinical practice.

A Bright Future Ahead

The 2026 DSPN Spine Summit represents a significant step for Matricelf as it strives to enhance treatment outcomes for individuals affected by paralysis due to spinal cord injuries. The insights and collaborations garnered from this leading medical event are expected to be crucial in facilitating the transition from innovative research to real-world patient applications.

In conclusion, Matricelf’s involvement in the DSPN Spine Summit highlights its dedication to pioneering transformative therapies that can significantly improve quality of life for patients facing the challenges associated with spinal cord injuries. As the company prepares for its participation, it looks forward to forging new relationships and broadening its impact on the regenerative medicine landscape.

Conclusion

Matricelf Ltd. is set to harness the opportunities presented at the 2026 Digital Spine & Pain Neuroscience Summit, marking a clear commitment to the advancement of spine health technology and innovative treatment options for spinal cord injuries. By participating in this prestigious gathering, Matricelf not only aims to share its breakthroughs but also to learn from the best minds in the field, fostering a future where effective, regenerative therapies are accessible to all who need them.